Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine versus Botox for severe drooling in neurologic disease
2007-003017-14Phase 4Active
- Sponsor
- Käkkliniken, Universitetssjukhuset i Linköping
- Start
- Jun 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of atropine and botulinum toxin type A in hypersalivation (2 arms), sponsored by Käkkliniken, Universitetssjukhuset i Linköping. Started Jun 2007; status: active.
02
Drugs
atropinebotulinum toxin type A
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2007-003017-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003017-14.